Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Childhood Hodgkin survivors have neurocognitive impairment

Publish date:: December 7, 2020

Key clinical point: Long-term survivors of childhood Hodgkin lymphoma may need evaluation for neurocognitive problems.

Major finding: Compared with sibling controls, Hodgkin survivors had lower scores on four neurocognitive domains.

Study details: A surveillance study of 1,564 survivors and 725 controls.

Disclosures: The CCSS is funded by the National Cancer Institute. Drs. Williams, Palawi, and Kelly all reported no relevant conflicts of interest to disclose.

Citation:

Williams AM et al. ASH 2020, Abstract 370.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Rare Diseases

Childhood Hodgkin survivors have neurocognitive impairment,

Gene-replacement therapy shows promise in X-linked myotubular myopathy,

Ataluren delays disease milestones in patients with nonsense mutation DMD,

Nusinersen provides continued benefits to presymptomatic children with SMA,

CBD for LGS: Fewer seizures, but thrombocytopenia risk,